berberine has been researched along with Cognition Disorders in 6 studies
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) has been reported to ameliorate diabetes and diabetic encephalopathy (DE)." | 1.48 | Berberine Improves Diabetic Encephalopathy Through the SIRT1/ER Stress Pathway in db/db Mice. ( Chen, YB; Cheng, SY; Fang, JS; Hao, XY; Li, HY; Luo, NC; Luo, S; Wang, Q; Wang, XC; Xu, YM; Zhang, SJ, 2018) |
| "Berberine (BBR) has neuroprotective effects on many brain diseases, including Alzheimer's disease (AD)." | 1.48 | Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases. ( Cai, Z; Chen, Y; He, W; Wang, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, HY | 1 |
| Wang, XC | 1 |
| Xu, YM | 1 |
| Luo, NC | 1 |
| Luo, S | 1 |
| Hao, XY | 1 |
| Cheng, SY | 1 |
| Fang, JS | 1 |
| Wang, Q | 1 |
| Zhang, SJ | 1 |
| Chen, YB | 1 |
| Cai, Z | 1 |
| Wang, C | 1 |
| He, W | 1 |
| Chen, Y | 1 |
| Yu, D | 1 |
| Tao, BB | 1 |
| Yang, YY | 1 |
| Du, LS | 1 |
| Yang, SS | 1 |
| He, XJ | 1 |
| Zhu, YW | 1 |
| Yan, JK | 1 |
| Yang, Q | 1 |
| Kumar, A | 1 |
| Mishra, J | 1 |
| Chopra, K | 1 |
| Dhull, DK | 1 |
| Hung, TM | 1 |
| Na, M | 1 |
| Dat, NT | 1 |
| Ngoc, TM | 1 |
| Youn, U | 1 |
| Kim, HJ | 1 |
| Min, BS | 1 |
| Lee, J | 1 |
| Bae, K | 1 |
| Durairajan, SS | 1 |
| Liu, LF | 1 |
| Lu, JH | 1 |
| Chen, LL | 1 |
| Yuan, Q | 1 |
| Chung, SK | 1 |
| Huang, L | 1 |
| Li, XS | 1 |
| Huang, JD | 1 |
| Li, M | 1 |
6 other studies available for berberine and Cognition Disorders
| Article | Year |
|---|---|
Berberine Improves Diabetic Encephalopathy Through the SIRT1/ER Stress Pathway in db/db Mice.
Topics: Animals; Berberine; Biomarkers; Blood Glucose; Brain Diseases; Cognition Disorders; Conditioning, Ps | 2018 |
Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein | 2018 |
The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Berberine; Brain; Cell Survival; Cogniti | 2015 |
Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Cognition Disorders; Ma | 2016 |
Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii.
Topics: Acetylcholinesterase; Alkaloids; Amnesia; Animals; Avoidance Learning; Berberine; Berberine Alkaloid | 2008 |
Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Topics: ADAM Proteins; ADAM10 Protein; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precur | 2012 |